Ubs Group Ag Accelerate Diagnostics, Inc Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.64 - $1.03 $7 - $11
11 Added 0.02%
50,811 $41,000
Q1 2023

May 12, 2023
BUY
$0.46 - $0.77 $23,000 - $38,500
50,000 Added 6250.0%
50,800 $35,000
Q4 2022

Feb 08, 2023
SELL
$0.51 - $17.1 $4,086 - $137,022
-8,013 Reduced 90.92%
800 $0
Q3 2022

Nov 10, 2022
SELL
$1.01 - $17.0 $35,127 - $591,260
-34,780 Reduced 79.78%
8,813 $13,000
Q2 2022

Aug 10, 2022
BUY
$0.54 - $1.41 $21,408 - $55,899
39,645 Added 1004.18%
43,593 $44,000
Q1 2022

May 16, 2022
SELL
$1.4 - $5.15 $14,397 - $52,962
-10,284 Reduced 72.26%
3,948 $6,000
Q4 2021

Feb 14, 2022
BUY
$4.27 - $6.97 $50,116 - $81,806
11,737 Added 470.42%
14,232 $74,000
Q3 2021

Nov 15, 2021
SELL
$5.31 - $8.25 $20,427 - $31,737
-3,847 Reduced 60.66%
2,495 $14,000
Q2 2021

Aug 13, 2021
SELL
$6.81 - $9.23 $78,144 - $105,914
-11,475 Reduced 64.4%
6,342 $51,000
Q1 2021

May 12, 2021
BUY
$7.99 - $15.0 $2,580 - $4,845
323 Added 1.85%
17,817 $148,000
Q4 2020

Feb 11, 2021
BUY
$7.04 - $11.7 $61,149 - $101,626
8,686 Added 98.61%
17,494 $133,000
Q3 2020

Nov 12, 2020
SELL
$9.98 - $18.04 $762,521 - $1.38 Million
-76,405 Reduced 89.66%
8,808 $94,000
Q2 2020

Jul 31, 2020
SELL
$7.49 - $15.16 $870,345 - $1.76 Million
-116,201 Reduced 57.69%
85,213 $1.29 Million
Q1 2020

May 01, 2020
SELL
$4.62 - $18.74 $27,502 - $111,559
-5,953 Reduced 2.87%
201,414 $1.68 Million
Q4 2019

Feb 14, 2020
BUY
$14.6 - $18.13 $663,132 - $823,464
45,420 Added 28.05%
207,367 $3.51 Million
Q3 2019

Nov 14, 2019
SELL
$16.62 - $23.92 $236,220 - $339,974
-14,213 Reduced 8.07%
161,947 $3.01 Million
Q2 2019

Aug 14, 2019
BUY
$17.79 - $22.88 $87,046 - $111,951
4,893 Added 2.86%
176,160 $4.03 Million
Q1 2019

May 14, 2019
SELL
$11.76 - $22.15 $390,408 - $735,335
-33,198 Reduced 16.24%
171,267 $3.6 Million
Q4 2018

Feb 14, 2019
BUY
$10.42 - $21.94 $90,758 - $191,097
8,710 Added 4.45%
204,465 $2.35 Million
Q3 2018

Nov 14, 2018
BUY
$20.4 - $24.6 $215,974 - $260,440
10,587 Added 5.72%
195,755 $4.49 Million
Q2 2018

Aug 14, 2018
BUY
$19.02 - $24.95 $272,518 - $357,483
14,328 Added 8.39%
185,168 $4.13 Million
Q1 2018

May 15, 2018
SELL
$22.55 - $29.9 $407,726 - $540,621
-18,081 Reduced 9.57%
170,840 $3.9 Million
Q4 2017

Feb 14, 2018
BUY
$18.0 - $30.0 $190,782 - $317,970
10,599 Added 5.94%
188,921 $4.95 Million
Q3 2017

Nov 14, 2017
BUY
$21.1 - $25.15 $277,844 - $331,175
13,168 Added 7.97%
178,322 $4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
20,287 Added 14.0%
165,154 $4.52 Million
Q1 2017

Nov 14, 2017
BUY
N/A
144,867
144,867 $3.51 Million

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email